Analogs of the anti-malaria drug mefloquine have broad-spectrum antifungal activity and are efficacious in a model of disseminated Candida auris infection.
Antimicrob Agents Chemother
; : e0130124, 2024 Oct 04.
Article
in En
| MEDLINE
| ID: mdl-39365066
ABSTRACT
Only three classes of antifungal drugs are currently in clinical use. Here, we report that derivatives of the malarial drug mefloquine have broad-spectrum antifungal activity including difficult-to-treat molds and endemic fungi. Pharmacokinetic and efficacy studies of NSC-4377 indicate that it penetrates the central nervous system and is active against Candida auris in vivo. These data strongly support the further development of mefloquine analogs as a potentially new class of antifungal molecules.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Antimicrob Agents Chemother
Year:
2024
Document type:
Article
Affiliation country:
United States
Country of publication:
United States